HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Facilities
SectorN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees262,000
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable
HCA Healthcare (NYSE:HCA) Frequently Asked Questions
What is HCA Healthcare's stock symbol?
HCA Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."
How often does HCA Healthcare pay dividends? What is the dividend yield for HCA Healthcare?
HCA Healthcare announced a quarterly dividend on Tuesday, January 28th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.43 per share on Tuesday, March 31st. This represents a $1.72 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Friday, February 28th. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.40. View HCA Healthcare's Dividend History.
How were HCA Healthcare's earnings last quarter?
HCA Healthcare Inc (NYSE:HCA) issued its quarterly earnings results on Tuesday, January, 28th. The company reported $3.09 EPS for the quarter, hitting analysts' consensus estimates of $3.09. The business earned $13.52 billion during the quarter, compared to analysts' expectations of $13.37 billion. The firm's revenue for the quarter was up 10.2% on a year-over-year basis. During the same period in the prior year, the firm earned $3.01 EPS. View HCA Healthcare's Earnings History.
When is HCA Healthcare's next earnings date?
What guidance has HCA Healthcare issued on next quarter's earnings?
HCA Healthcare updated its FY 2020
Pre-Market earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of 11.30-12.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.62. The company issued revenue guidance of $53.5-55.5 billion, compared to the consensus revenue estimate of $53.95 billion.
What price target have analysts set for HCA?
15 brokers have issued 1-year price targets for HCA Healthcare's shares. Their forecasts range from $135.00 to $186.00. On average, they anticipate HCA Healthcare's stock price to reach $166.07 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price. View Analyst Price Targets for HCA Healthcare.
What is the consensus analysts' recommendation for HCA Healthcare?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCA Healthcare in the last year. There are currently 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HCA Healthcare.
Has HCA Healthcare been receiving favorable news coverage?
Media stories about HCA stock have been trending negative on Sunday, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. HCA Healthcare earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for HCA Healthcare.
Are investors shorting HCA Healthcare?
HCA Healthcare saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 3,750,000 shares, a decrease of 12.0% from the January 15th total of 4,260,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is currently 2.7 days. Approximately 1.4% of the company's stock are sold short. View HCA Healthcare's Current Options Chain.
Who are some of HCA Healthcare's key competitors?
Some companies that are related to HCA Healthcare include National HealthCare (NHC), Hanger (HNGR), Acadia Healthcare (ACHC), Brookdale Senior Living (BKD), Capital Senior Living (CSU), Community Health Systems (CYH), Encompass Health (EHC), Five Star Senior Living (FVE), Select Medical (SEM), Tenet Healthcare (THC), The Ensign Group (ENSG), U.S. Physical Therapy (USPH) and Universal Health Services (UHS).
What other stocks do shareholders of HCA Healthcare own?
Who are HCA Healthcare's key executives?
HCA Healthcare's management team includes the folowing people:
- Mr. Samuel N. Hazen, CEO & Director (Age 59)
- Mr. William B. Rutherford, Exec. VP & CFO (Age 55)
- Mr. Charles J. Hall, Pres of National Group (Age 66)
- Mr. Jon Mack Foster, Pres of American Group (Age 57)
- Dr. Thomas F. Frist Jr., Founder & Chairman Emeritus (Age 80)
Who are HCA Healthcare's major shareholders?
HCA Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (3.45%), Magellan Asset Management Ltd (3.00%), Longview Partners Guernsey LTD (2.79%), FMR LLC (1.71%), LSV Asset Management (1.22%) and Goldman Sachs Group Inc. (0.97%). Company insiders that own HCA Healthcare stock include A Bruce Moore Jr, Bill B Rutherford, Charles J Hall, Christopher F Wyatt, Deborah M Reiner, J William Morrow, Jane D Englebright, Jon M Foster, Jonathan B Perlin, Joseph A Sowell III, Kathleen M Whalen, Kathryn A Torres, Michael S Cuffe, Patricia F Elcan, Robert A Waterman, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Healthcare.
Which institutional investors are selling HCA Healthcare stock?
HCA stock was sold by a variety of institutional investors in the last quarter, including Magellan Asset Management Ltd, FMR LLC, Great West Life Assurance Co. Can, Bank of Montreal Can, PNC Financial Services Group Inc., Hexavest Inc., Massachusetts Financial Services Co. MA and Alyeska Investment Group L.P.. Company insiders that have sold HCA Healthcare company stock in the last year include A Bruce Moore Jr, Christopher F Wyatt, Deborah M Reiner, Jane D Englebright, Jon M Foster, Joseph A Sowell III, Kathleen M Whalen, Michael S Cuffe and Robert A Waterman. View Insider Buying and Selling for HCA Healthcare.
Which institutional investors are buying HCA Healthcare stock?
HCA stock was bought by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Assenagon Asset Management S.A., Goldman Sachs Group Inc., Los Angeles Capital Management & Equity Research Inc., Schroder Investment Management Group, Banco Santander S.A., AJO LP and Credit Suisse AG. Company insiders that have bought HCA Healthcare stock in the last two years include Patricia F Elcan and Thomas F Frist Jr. View Insider Buying and Selling for HCA Healthcare.
How do I buy shares of HCA Healthcare?
Shares of HCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is HCA Healthcare's stock price today?
One share of HCA stock can currently be purchased for approximately $149.57.
MarketBeat Community Rating for HCA Healthcare (NYSE HCA)
MarketBeat's community ratings are surveys of what our community members think about HCA Healthcare and other stocks. Vote "Outperform" if you believe HCA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCA will underperform the S&P 500 over the long term. You may vote once every thirty days.
